Meet the growing ASX large cap that's beating the COVID-19 slowdown

The AMCOR PLC/IDR UNRESTR (ASX: AMC) share price is outperforming the market after it upgraded its profit guidance. But it isn't the only one to watch.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The AMCOR PLC/IDR UNRESTR (ASX: AMC) share price is outperforming the market after it upgraded its profit guidance.

Shares in the global packaging giant jumped 0.7% to $13.82 when the S&P/ASX 200 Index (Index:^AXJO) slumped 1.2% at the time of writing.

You will be hard pressed to find another stock that is lifting its full-year forecast and growing earnings in this coronavirus-stricken market.

Profit growth in challenging market

But Amcor is doing just that as management unveiled its quarterly results. Underlying earnings per share (EPS) jumped 13.7% in constant currency terms to 44.7 US cents in the nine months ended March 31.

Underlying earnings before interest and tax (EBIT) lifted 6.9% to US$1.06 billion even as revenue dipped a modest 1.8% to US$9.33 billion over the period.

Earnings guidance upgrade

The good news didn't stop there. Amcor increased its FY20 for the second consecutive quarter with management now tipping a 11% to 12% increase in EPS from its previous guidance of 7% to 10%.

While Amcor isn't immune from the global recession due to the COVID-19 lockdown, its business is deemed by governments as an essential service.

This means its 250 plants around the world have largely continued to operate as Amcor services clients in defensive sectors like healthcare, food and beverages.

Further, the group isn't reporting an increase in operating costs due to disruptions caused by the pandemic.

Impact of COVID-19

Interestingly, management commented that the impact of COVID-19 on its business is unclear. While some parts of its business have slowed, others have benefitted from the crisis.

For instance, Amcor experienced good demand from healthcare globally and most food and beverage end markets were relatively strong in developed countries.

However, the group experienced weakness in emerging markets, including China and India.

Other quality ASX stocks to watch

Amcor's integration of its recent acquisition of Bemis is also proceeding well. It's managed to deliver pre-tax cost savings of US$55 million this financial year and expects to achieve US$180 million by end of FY22.

And unlike many other blue-chip ASX companies, including the big banks like Commonwealth Bank of Australia (ASX: CBA), there is no need to worry about dividend cuts from Amcor.

The group declared a quarterly dividend of 11.5 US cents a share (or 17.7 Australian cents) and said it expected to complete its $500 million on market share buyback by the end of this fiscal year.

Amcor isn't the only defensive growth stock that's well placed to outperform in this market. I also rate glove maker Ansell Limited (ASX: ANN) and ship builder Austal Limited (ASX: ASB) very highly.

Brendon Lau owns shares of Austal Limited, Ansell Limited and Commonwealth Bank of Australia. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Austal Limited. The Motley Fool Australia owns shares of and has recommended Amcor Limited. The Motley Fool Australia has recommended Ansell Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough start to the trading week this Monday.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

Paper aeroplane going down on a chart, symbolising a falling share price.
Travel Shares

Why Web Travel shares are sliding as fresh takeover hopes return

Web Travel shares sink as investors weigh CEO succession and takeover risk.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 4DMedical, Brainchip, Catapult, and Star Entertainment shares are falling today

These shares are starting the week in the red. But why>

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »